Marrone Bio Innovati
MBII
Delayed Nasdaq - 10/20 09:58:50 pm
0.9199USD
-5.16%
Upcoming events

- No events available -

Past Events
10/05/17 | 04:30pmMarcum MicroCap Conference
09/11/17 | 04:25pmRodman & Renshaw Global Investment Conference
08/24/17 | 05:30pmSouthern California Investor Conference
08/14/17Interim 2017 Earnings Release
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
14,0
14,6
-3,6%

22,2
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-21,4
-20,5
-4,4%

-18,4
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-23,7
-23,8
0,76%

-21,4
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-31,1
-30,5
-1,7%

-28,5
Net income
Million $
Released
Forecast
Spread
-31,1
-30,5
-1,7%

-28,5
EPS
 $
Released
Forecast
Spread
-1,26
-1,14
-11%

-1,01
Announcement Date03/29/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread
6,48
7,06
-8,3%

4,90
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-4,90
-3,97
-24%

-4,40
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-5,42
-5,01
-8,0%

-5,40
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-7,39
-6,78
-8,9%

-7,30
Net income
Million $
Released
Forecast
Spread
-7,39
-6,78
-8,9%

-7,30
EPS
 $
Released
Forecast
Spread
-0,25
-0,21
-22%

-0,25
Announcement Date08/14/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise